Technical Analysis for HOOK - HOOKIPA Pharma Inc.

Grade Last Price % Change Price Change
C 0.72 -0.14% 0.00
HOOK closed down 0.14 percent on Monday, March 18, 2024, on 69 percent of normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
20 DMA Resistance Bearish -0.14%
Crossed Above 200 DMA Bullish -0.14%
Crossed Above 50 DMA Bullish -0.14%
Inside Day Range Contraction -0.14%
Wide Bands Range Expansion -0.14%
Fell Below 20 DMA Bearish 4.45%
Fell Below 200 DMA Bearish 4.45%
Fell Below 50 DMA Bearish 4.45%

   Recent Intraday Alerts

Alert Time
50 DMA Support about 11 hours ago
200 DMA Support about 12 hours ago
Fell Below Previous Day's Low about 15 hours ago
Down 5% about 15 hours ago
60 Minute Opening Range Breakdown about 16 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

HOOKIPA Pharma Inc. Description

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Hepatitis B Transplantation Immunodeficiency Hepatitis B Virus Viral Disease Papillomavirus Gilead Sciences Immunotherapeutics Kidney Transplant

Is HOOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.05
52 Week Low 0.41
Average Volume 567,145
200-Day Moving Average 0.70
50-Day Moving Average 0.71
20-Day Moving Average 0.73
10-Day Moving Average 0.75
Average True Range 0.06
RSI (14) 48.98
ADX 18.15
+DI 16.70
-DI 18.94
Chandelier Exit (Long, 3 ATRs) 0.68
Chandelier Exit (Short, 3 ATRs) 0.78
Upper Bollinger Bands 0.84
Lower Bollinger Band 0.62
Percent B (%b) 0.44
BandWidth 29.89
MACD Line 0.01
MACD Signal Line 0.02
MACD Histogram -0.0073
Fundamentals Value
Market Cap 69.32 Million
Num Shares 96.6 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -0.90
Price-to-Sales 3.25
Price-to-Book 0.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.78
Resistance 3 (R3) 0.77 0.75 0.77
Resistance 2 (R2) 0.75 0.73 0.75 0.76
Resistance 1 (R1) 0.73 0.72 0.72 0.74 0.76
Pivot Point 0.71 0.71 0.70 0.71 0.71
Support 1 (S1) 0.69 0.69 0.68 0.70 0.67
Support 2 (S2) 0.67 0.68 0.67 0.67
Support 3 (S3) 0.65 0.67 0.67
Support 4 (S4) 0.66